Shares of Sage Therapeutics were climbing fast on Thursday after the company announced positive mid-stage trial results on one of its depression drugs. The company saw its market cap soar over $2.5 billion as traders gobbled up shares. Shares closed up over 70%. It was the biggest one day ever price percentage gain for the … Continue reading “Sage Therapeutics Shares Skyrocket on Positive Depression Drug Trial Results”
Tag: anti depressant
Biotech & Pharma
Neuralstem Explodes on Positive Phase 2 Clinical Data
Shares of Neuralstem were exploding in Tuesday trading and closed the day up 175% after…
December 5, 2017